How to treat Urticaria?

['Ehendu ko kuatiarogue']

Mba'éichapa ikatu oñepohano urticaria?

Urticaria, ojekuaáva avei urticaria-ramo, ha'e peteĩ mba'asy pire rehe osẽva, ñandu ha hu'u ikatu ojehecha opárupi ñande retére.

Ikatu ojehu heta mba'ére, oikehápe reacción alérgica, infección térã ambue mba'asy.

Urticaria ñepohano oiko ojehecha rire mba'eichaguápa ha mba'érepa.

Ko'ápe oĩ opáichagua ñepohano rehegua:

1. Antihistaminas: Ko'ã pohã oipytyvõ ombovevúi haguã ñandu ha hu'u ojoko rupi histamina rembiapo, peteĩ producto químico osẽva ñande retégui peteĩ reacción alérgica aja.

Umi antihistamínico ojeheróva " over-the-counter" ha'eháicha difenhidramina (Benadryl) térã loratadina (Claritin) ikatu oporombohasy sa'iete.

Umi káso ivaivéva, peteĩ pohãnohára ikatu omoĩ pohã imbaretevéva.

2. Corticosteroides: Umi káso antihistamínico ndoikoporãihápe, ikatu oje'e corticosteroides prednisona-icha omboguejy hag̃ua inflamación ha ojoko hag̃ua sistema inmunológico.

Ko'ã pohã oje'u jepi juru rupive ha ikatu oporomonguera pya'e.

3. Immunosupresores: Urticaria crónica-pe, ndoikóiramo ambue ñepohano, ikatu oje'e toñeme'ẽ fármaco inmunosupresor taha'e ciclosporina térã metotrexato, ohapejoko hag̃ua sistema inmunológico ha omboguejy hag̃ua inflamación.

4. Omalizumab: ko pohã hína anticuerpo monoclonal inyectable ojuhúva ha ohapejokóva inmunoglobulina E (IgE), peteĩ proteína oĩva reacción alérgica-pe.

Ojeporu jepi urticaria crónica-pe, ndo'aporãiva ambue ñepohãnopuku ndive.

5. Tojejoko umi mba'e oporombohasýva: Ojehechakuaa ha ojehapejoko umi mba'e oporombohasýva ikatu oipytyvõ ojehapejoko hag̃ua umi mba'asy.

Ikatu hína okakuaa ñande retepýpe umi mbaʼasy, por ehémplo umi aliménto, pohã, ñatiʼũ ñanderupytýva, haku, roʼy térã kuarahy.

6. Kompresa ro'ysã: Oñemoĩvo peteĩ compresa ro'ysã pe hasýva ári ikatu ombovevúi ñekytĩ ha hu'u.

7. Ombohykuéva: Ojeporukuaa omokã hag̃ua ñekytĩngue ha ombovevúi hag̃ua hu'u.

Oñembojehe'a peteĩ ao he'õva pe tenda hasývare ha upéi oñemoĩ hi'ári peteĩ ao hakuáva ani hag̃ua osoropa.

8. Fototerapia: luz ultravioleta jehechauka ikatu oipytyvõ sistema inmunológico-pe ha omboguejy inflamación umi urticaria crónica apytépe.

Iporã oñepohano pohãnohára oñandukuaáva ndive.

Ikatu oipytyvõ ojeikuaa hag̃ua mba'érepa oiko ha he'i mba'eichagua ñepohãnópa iporãve.

['Jehechapy']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Deleanu D, Nedelea I, Petricau C, Leru P, Dumitrascu D, Muntean A: Clinical impact of omalizumab in refractory chronic urticaria: One centre experience. Exp Ther Med. 2019, 18 (6): 5078-5081.

Grundmann SA, Kiefer S, Luger TA, Brehler R: Delayed pressure urticaria - dapsone heading for first-line therapy? J Dtsch Dermatol Ges. 2011, 9 (11): 908-12.

Staumont-Sallé D, Piette F, Delaporte E: [Etiological diagnosis and treatment of chronic urticaria]. Rev Med Interne. 2003, 24 (1): 34-44.

Akashi R, Ishiguro N, Shimizu S, Kawashima M: Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis: effectiveness of eradication therapy for Helicobacter pylori. J Dermatol. 2011, 38 (8): 761-6.

Calogiuri G, Nettis E, Mandurino-Mirizzi A, Di Leo E, Macchia L, Foti C, Vacca A, Kounis NG: Omalizumab for the Treatment of Persistent Drug Induced Urticaria Elicited by Thienopyridines: A Case Report. Antiinflamm Antiallergy Agents Med Chem. 2020, 19 (3): 335-339.

['Ñemboyke: pohã']

["Ko página web niko ñehekombo'e ha marandu rehegua añónte, ndaha'éi ñeporandu térã ñepytyvõ pohãnohárape."]

["Ko marandu oñeme'ẽva ndojeporúi va'erã ojeikuaa térã oñepohano hag̃ua peteĩ problema de salud térã mba'asy, ha umi tapicha ohekáva consejo médico ha'eñoháme oñe'ẽva'erã peteĩ pohanohára ikatupyrýva ndive."]

["Ejesareko ta'ãngamýi ñandutigua omoheñóiva mbohovái porandukuérape, noĩporãi ojeipapávo papapy rehegua, techapyrã, tapichakuéra hasýva peteĩ mba'asýpe."]

["Akóinte eheka ne pohãnohára térã ambue pohanohára ikatupyrýva ñe'ẽ peteĩ mba'asýpe. Ani araka'eve remboyke térã reha'arõ'ỹ rehekávo ñe'ẽ pohanohára ikatupyrýva ñe'ẽ remoñe'ẽre ko ñanduti rendápe. Reimo'ãramo ikatuha reikotevẽ peteĩ mba'e hasýva, ehenoikuaa 911 térã tereho pya'e tasyópe. Ko ñanduti renda térã ijeporu ndojapói mba'eveichagua pohanohára ha hasýva jokupyty. BioMedLib, imba'apohára térã oimeraẽ tapicha oipytyvõva ko ñanduti rendápe, nomboajéi mba'eve, he'íva térã he'iséva, marandu oĩva ko'ápe térã ijeporu."]

['Copyright: Copyright']

["Pe Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (DMCA) ome'ẽ recurso umi copyright járape ogueroviáva umi mba'e ojehechaukáva Internet-pe opokovaiha iderecho rehe EE.UU. léi jehaiporãmby rehegua rupive. "]

["Rogueroviáramo añetehápe oimeraẽ mba'e térã tembiporu ojepurukuaáva ore ñanduti renda térã tembipurupyahu rupive opyrũha ne derécho rehe, nde (térã ne rembijokuái) ikatu oremondo peteĩ ñemomarandu ojerurévo ojeipe'a hag̃ua upe mba'e térã tembiporu, térã ojejokopa hag̃ua ijeike. "]

['Umi ñemomarandu oñemog̃uahẽva\'erã kuatia rupive, correo electrónico rupive (ojehecháta "Contacto" pe).']

["DMCA ojerure ne ñemomarandu rehe ejaposégui mba'evai ejaposéva rehe toike ko'ã mba'e: (1) tembiapo ojejaposéva rehegua ha'éva mba'evai; (2) jehaipy ha mba'ekuaarã ome'ẽva oréve jehaipyre ha'éva mba'evai ha ome'ẽva oréve pa'ũ rojuhu hag̃ua; (3) ne ñanduti veve, ne rendaite, ne pumbyry papapy ha ne ñanduti veve; (4) ñe'ẽme'ẽ erekóva rejeroviaha pe mba'evai ejaposéva rehe ndojeruréiha mba'evai apohára, imaranduhára térã léi."]

["5. peteî declaración nde rejapóva, remoîva nde réra ha remoîva'erâha nde jurúpe, umi mba'e oîva ñemomarandúpe oîmbaha añetehápe ha rerekoha pokatu remoañete haguâ umi derecho oje'éva nde rehe ojepoko vaiha;"]

["ha (6) peteĩ firma física térã electrónica copyright jára rehegua térã peteĩ tapicha omoneĩva oporoñemomba'e hag̃ua copyright jára rérape. "]

["Ndoikéi ramo opaite ko'ã mba'e ikatu ombohape nde denuncia ñemboguata."]

['Ñemboheraguapy']

["Remba'eporanduséramo térã ereko hag̃ua ne remiandu ehai oréve."]

How to treat urticaria?

Urticaria, commonly known as hives, is a skin condition characterized by itchy, raised welts that can appear on any part of the body.

It can be caused by various factors, including allergic reactions, infections, or underlying medical conditions.

Treatment for urticaria depends on the severity of the condition and the underlying cause.

Here are some common treatment options:

1. Antihistamines: These medications help to reduce itching and swelling by blocking the effects of histamine, a chemical released by the body during an allergic reaction.

Over-the-counter antihistamines such as diphenhydramine (Benadryl) or loratadine (Claritin) can be effective in mild cases.

In more severe cases, a doctor may prescribe stronger antihistamines.

2. Corticosteroids: In cases where antihistamines are not effective, corticosteroids such as prednisone may be prescribed to reduce inflammation and suppress the immune system.

These medications are usually taken orally and can provide quick relief.

3. Immunosuppressants: In cases of chronic urticaria that do not respond to other treatments, immunosuppressant drugs such as cyclosporine or methotrexate may be prescribed to suppress the immune system and reduce inflammation.

4. Omalizumab: This medication is an injectable monoclonal antibody that targets and blocks immunoglobulin E (IgE), a protein involved in allergic reactions.

It is typically used for chronic urticaria that does not respond to other treatments.

5. Avoid triggers: Identifying and avoiding triggers that cause urticaria can help prevent outbreaks.

Common triggers include certain foods, medications, insect bites, and exposure to heat, cold, or sunlight.

6. Cold compress: Applying a cold compress to the affected area can help reduce itching and swelling.

7. Wet wraps: Wet wraps can be used to soothe itching and reduce inflammation.

A damp cloth is wrapped around the affected area, and then a dry cloth is placed over it to retain moisture.

8. Phototherapy: Exposure to ultraviolet light can help suppress the immune system and reduce inflammation in some cases of chronic urticaria.

It is important to consult a healthcare professional for proper diagnosis and treatment of urticaria.

They can help determine the underlying cause and recommend the most appropriate treatment plan.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.